PHARMA NEWS

Get the latest NEWS of Pharma World

CHMP recommends first oral-only treatment for sleeping sickness
Pharma News
By admin / November 20, 2018

CHMP recommends first oral-only treatment for sleeping sickness

EMA’s human medicines committee (CHMP)...

Read More
Philips debuts noninvasive ventilator with high flow therapy to improve patient care
Pharma News
By admin / November 20, 2018

Philips debuts noninvasive ventilator with high flow therapy to improve patient care

Royal Philips (NYSE: PHG, AEX:...

Read More
Pharma News
By admin / November 19, 2018

Panalpina’s new logistics center in Singapore obtains GDP certification

After Bogotá in August, Panalpina...

Read More
Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound
Pharma News
By admin / November 19, 2018

Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound

Pharmaceutical company Pharmaxis (ASX: PXS)...

Read More
NIH scientists combine technologies to view the retina in unprecedented detail
Pharma News
By admin / November 19, 2018

NIH scientists combine technologies to view the retina in unprecedented detail

By combining two imaging modalities...

Read More
Shire Announces New HELP Study(TM) Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific Meeting
Pharma News
By admin / November 19, 2018

Shire Announces New HELP Study(TM) Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific Meeting

Shire plc (LSE: SHP, NASDAQ:...

Read More
On World Diabetes Day, P.D. Hinduja Hospital and MRC conduct diabetes check-up of Mumbai Traffic Police
Pharma News
By admin / November 16, 2018

On World Diabetes Day, P.D. Hinduja Hospital and MRC conduct diabetes check-up of Mumbai Traffic Police

On the occasion of World...

Read More
NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders
Pharma News
By admin / November 16, 2018

NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders

NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP,...

Read More
Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) Tablets
Pharma News
By admin / November 16, 2018

Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) Tablets

Exelixis, Inc. (Nasdaq: EXEL) today...

Read More
Biohaven Pharmaceuticals Reports Third Quarter 2018 Financial And Recent Business Results
Pharma News
By admin / November 16, 2018

Biohaven Pharmaceuticals Reports Third Quarter 2018 Financial And Recent Business Results

Strong and consistent progress continues...

Read More
1 … 87 88 89 90 91 … 154
Offers